RN7SL610P

Across TCGA pan-cancer cohorts, RN7SL610P RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RN7SL610P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RN7SL610P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL610P expression acts as an unfavorable survival marker, although some lineages such as DLBC and SKCM show a favorable association.

KIRC, CHOL, and LGG are the cancer types where RN7SL610P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.519	0.679	.005	39	view →
CHOL	DFS	Quartile	All	0.121	0.584	.001	32	view →
LGG	DFS	Median	All	0.632	0.817	<.001	27	view →
DLBC	DFS	Median	II,III,IV	1.000	0.667	.005	26	view →
SKCM	DFS	Median	III,IV	0.600	0.379	.001	13	view →
LIHC	DFS	Quartile	II,III,IV	0.254	0.500	.019	12	view →
THCA	OS	Tertile	III,IV	0.328	0.968	.019	12	view →
ESCA	DFS	Median	All	0.289	0.425	.010	9	view →
UVM	OS	Quartile	III,IV	0.185	0.837	.002	8	view →
MESO	DFS	Quartile	IV	0.242	0.697	.015	6	view →
LAML	DFS	Median	All	0.656	0.466	.038	6	view →
LUAD	DFS	Median	IV	1.000	0.351	.049	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

RN7SL610P–KIRC (OS)

Open the KIRC breakdown →